Iowa Pharmacy Board's Bill Aims to Improve System for Tracking Opioid Prescriptions

Jan 2, 2018

The Iowa Board of Pharmacy has filed a bill that would help fill gaps in the state’s system for tracking prescription opioid suppliers in an effort to identify patients who might be abusing prescription painkillers.

Pharmacies currently have to submit information to the Iowa prescription monitoring program (PMP) when they dispense opioids. The pharmacy board’s bill would require prescribers who supply opioids to also add that information to the PMP.

"As long as you have a segment of the dispensers—in other words, the prescribing practitioners—that are supplying those drugs to patients and not reporting that information to the PMP, then you don’t have a complete record of the patient’s prescriptions for controlled substances," says Terry Witkowski, executive officer of the Iowa Board of Pharmacy.

The bill would not require doctors to check those records before writing prescriptions for opioids. Improving PMP participation is often a key recommendation from public health professionals who study the opioid epidemic. 

Witkowski says the board hopes planned technological upgrades to the PMP will encourage more prescribers in Iowa to use it. She says the board wants those upgrades done by early April, but a contract hasn’t been finalized for that work.

The bill would also allow the pharmacy board to use the PMP to identify patients who might be at risk for abusing prescription drugs, and then notify their doctors and pharmacists.

"It’s still not a mandatory thing," Witkowski says. "It’s not going to provide them with any statements that say you cannot prescribe for this patient, or your patient appears to be addicted, or anything like that. It’s just letting them know that there may be some issues they want to take a look at."

The pharmacy board’s bill would also change the existing PMP advisory council to an advisory committee. Witkowski says that would give the group more flexibility, with members appointed by the Board of Pharmacy instead of the governor.

Lawmakers tasked with submitting opioid-related recommendations to the governor by mid-November 2017 have yet to do so. The committee issued a report in mid-December that did not include recommendations.